Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Adler

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|June 30, 2009
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brainKhalid Benamar, Menachem Yondorf, Ellen B Geller, et al.
Infection and Immunity|November 22, 2005
Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12Pu Feng, Qiana M Wilson, Joseph J Meissler, et al.
Journal of Neuroimmunology|July 21, 2007
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsToby K Eisenstein, Joseph J Meissler, Qiana Wilson, et al.
Life Sciences|November 1, 2005
The dynamic relationship between mu and kappa opioid receptors in body temperature regulationXiaohong Chen, Daniel B McClatchy, Ellen B Geller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermiaS M Rawls, A Cowan, R J Tallarida, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2009
Intrahypothalamic injection of the HIV-1 envelope glycoprotein induces fever via interaction with the chemokine systemKhalid Benamar, Saad Addou, Menachem Yondorf, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermiaS M Rawls, R J Tallarida, A M Gray, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2004
GABAA receptors modulate cannabinoid-evoked hypothermiaS M Rawls, R J Tallarida, D A Kon, et al.
Microvascular Research|April 1, 2009
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMing Zhang, Martin W Adler, Mary E Abood, et al.
Brain Research|August 23, 2003
NMDA receptors modulate morphine-induced hyperthermiaScott M Rawls, Martin W Adler, John P Gaughan, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|June 30, 2009
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brainKhalid Benamar, Menachem Yondorf, Ellen B Geller, et al.
Infection and Immunity|November 22, 2005
Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12Pu Feng, Qiana M Wilson, Joseph J Meissler, et al.
Journal of Neuroimmunology|July 21, 2007
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsToby K Eisenstein, Joseph J Meissler, Qiana Wilson, et al.
Life Sciences|November 1, 2005
The dynamic relationship between mu and kappa opioid receptors in body temperature regulationXiaohong Chen, Daniel B McClatchy, Ellen B Geller, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermiaS M Rawls, A Cowan, R J Tallarida, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2009
Intrahypothalamic injection of the HIV-1 envelope glycoprotein induces fever via interaction with the chemokine systemKhalid Benamar, Saad Addou, Menachem Yondorf, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermiaS M Rawls, R J Tallarida, A M Gray, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2004
GABAA receptors modulate cannabinoid-evoked hypothermiaS M Rawls, R J Tallarida, D A Kon, et al.
Microvascular Research|April 1, 2009
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMing Zhang, Martin W Adler, Mary E Abood, et al.
Brain Research|August 23, 2003
NMDA receptors modulate morphine-induced hyperthermiaScott M Rawls, Martin W Adler, John P Gaughan, et al.
Pageof 6